Alivus Life Sciences Limited (NSE:ALIVUS)

India · Delayed Price · Currency is INR

915.05

+5.05 (0.55%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018
Active Pharmaceutical Ingredient (API)	23.87B	22.83B	21.61B	21.23B	18.85B
Active Pharmaceutical Ingredient (API) Growth	4.54%	5.64%	1.79%	12.63%	22.63%
Total	23.87B	22.83B	21.61B	21.23B	18.85B
Total Growth	4.54%	5.64%	1.79%	12.63%	22.63%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018
India	11.52B	11.66B	11.33B	11.52B	10.48B
India Growth	-1.21%	2.95%	-1.64%	9.91%	33.10%
outside India	12.35B	11.17B	10.28B	9.71B	8.37B
outside India Growth	10.55%	8.61%	5.86%	16.04%	11.63%
Total	23.87B	22.83B	21.61B	21.23B	18.85B
Total Growth	4.54%	5.64%	1.79%	12.63%	22.63%

Source: S&P Global Market Intelligence.